ACADIAN ASSET MANAGEMENT LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 14 filers reported holding ARCA BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q4 2021$123,000
-10.9%
57,822
+176.6%
0.00%
-100.0%
Q2 2020$138,000
+72.5%
20,908
-26.4%
0.00%
Q1 2020$80,000
-19.2%
28,423
+64.0%
0.00%
Q4 2019$99,000
+6.5%
17,3330.0%0.00%
Q3 2019$93,000
-27.3%
17,3330.0%0.00%
-100.0%
Q2 2019$128,00017,3330.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
BML Capital Management, LLC 706,930$1,406,7911.22%
Newtyn Management, LLC 519,765$1,034,3320.20%
Murchinson Ltd. 52,800$100,6800.01%
Marquette Asset Management, LLC 17,318$34,4630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$93,4270.00%
Tekla Capital Management LLC 32,461$64,5970.00%
OSAIC HOLDINGS, INC. 57$1130.00%
DIMENSIONAL FUND ADVISORS LP 42,502$84,5790.00%
Parallel Advisors, LLC 244$4860.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
View complete list of ARCA BIOPHARMA INC shareholders